...
首页> 外文期刊>Journal of neurotrauma >Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis
【24h】

Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis

机译:创伤性脑损伤诱导的急性肺损伤:激活和抑制神经呼吸 - 炎症轴的证据

获取原文
获取原文并翻译 | 示例
           

摘要

Approximately 20-25% of traumatic brain injury (TBI) subjects develop acute lung injury (ALI), but the pathomechanisms of TBI-induced ALI remain poorly defined. Our previous work has shown that the inflammasome plays a critical role in TBI-induced secondary pathophysiology and that inflammasome proteins are released in extracellular vesicles (EV) after TBI. Here we investigated whether EV-mediated inflammasome signaling contributed to the etiology of TBI-induced ALI. C57/BL6 male mice were subjected to controlled cortical impact (CCI), and the brains and lungs were examined for inflammasome activation and ALI at 4 and 24 h after TBI. We show that TBI releases EV containing inflammasome proteins into serum that target the lung to cause ALI, supporting activation of a neural-respiratory-inflammasome axis. Administration of a low-molecular-weight heparin (enoxaparin, a blocker of EV uptake) or treatment with a monoclonal antibody against apoptosis speck-like staining protein containing a caspase recruitment domain (anti-ASC) after adoptive transfer of EV isolated from TBI-injured mice significantly inhibited inflammasome activation in the lungs of recipient mice resulting in improved ALI scores.This axis constitutes an important arm of the innate inflammatory response in lung pathology after TBI and targeting this axis represents a novel therapeutic treatment for TBI-induced ALI.
机译:大约20-25%的创伤性脑损伤(TBI)受试者产生急性肺损伤(ALI),但TBI诱导的ALI的病理机制仍然定义不足。我们以前的作品表明,炎性炎症在TBI诱导的二次病理生理学中起着关键作用,并且在TBI后,炎症组蛋白在细胞外囊泡(EV)中释放。在这里,我们研究了EV介导的炎性信号传导是否有助于TBI诱导的ALI的病因。对C57 / BL6进行控制的皮质冲击(CCI),在TBI后4和24小时检查炎症和肺部的脑膜活化和ALI。我们认为TBI将含有炎症蛋白的EV释放到靶向肺的血清,以引起Ali,支持激活神经呼吸 - 炎症轴线。施用低分子量肝素(Enoxaparin,EV摄取)或用单克隆抗体治疗含有含有胱天蛋白酶募集结构域(抗-ASC)的凋亡斑样染色蛋白的单克隆抗体治疗(抗-ASC),在从TBI中分离出来受伤的小鼠显着抑制受体小鼠肺部炎性的炎症,导致Ali评分改善.TBI后,轴构成肺病理学中的先天炎炎症反应的重要臂,靶向该轴代表了TBI诱导的Ali的新疗效治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号